Cavo, M; Sonneveld, P; Moreau, P; Blade, J; Goldschmidt, H; San Miguel, JF; Attal, M; Avet-Loiseau, H; Blau, WI; Facon, T; Gutierrez, N; Harousseau, JL; van der Holt, B; Jose Lahuerta, J; Lokhorst, H; Marit, G; Luisa Martin, M; Marzocchi, G; Palumbo, A; Patriarca, F; Petrucci, MT; Rosinol, L; Salwender, H; Terragna, C, Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies, in: Blood, 2012, pp. 749 - 749 (atti di: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012) [atti di convegno-abstract]
Brioli A;Zamagni E;Pasquali S;Tosi P;Tacchetti P;Perrone G;Pantani L;Petrucci A;Zannetti BA;Baccarani M;Cavo M, Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1248 - 1249 [articolo]
Zamagni E; Petrucci A; Tosi P; Tacchetti P; Perrone G; Brioli A; Pantani L; Zannetti B; Terragna C; Baccarani M; Cavo M., Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma., «ANNALS OF HEMATOLOGY», 2012, 91, pp. 419 - 426 [articolo]
Richardson PG; Delforge M; Beksac M; Wen P; Jongen JL; Sezer O; Terpos E; Munshi N; Palumbo A; Rajkumar SV; Harousseau JL; Moreau P; Avet-Loiseau H; Lee JH; Cavo M; Merlini G; Voorhees P; Chng WJ; Mazumder A; Usmani S; Einsele H; Comenzo R; Orlowski R; Vesole D; Lahuerta JJ; Niesvizky R; Siegel D; Mateos MV; Dimopoulos M; Lonial S; Jagannath S; Bladé J; Miguel JS; Morgan G; Anderson KC; Durie BG; Sonneveld P., Management of treatment-emergent peripheral neuropathy in
multiple myeloma., «LEUKEMIA», 2012, 26, pp. 595 - 608 [articolo]
Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; Miguel JS; Chim CS; Browne P; Einsele H; Waage A; Turesson I; Spencer A; Hajek R; Ludwig H; Hemminki K; Houlston R., MyelomA Genetics International Consortium., «LEUKEMIA & LYMPHOMA», 2012, 53, pp. 796 - 800 [articolo]
Musto P; Pagano L; Petrucci MT; Morabito F; Caravita T; Di Raimondo F; Baldini L; Tosi P; Bringhen S; Offidani M; Omede' P; Neri A; D'Auria F;
Bochicchio GB; Cavo M; Boccadoro M; Palumbo A, Primary plasma cell leukemia in the era of new drugs: has something changed?, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2012, 82, pp. 141 - 149 [articolo]
Moreau P; Richardson PG; Cavo M; Orlowski RZ; San Miguel JF; Palumbo A; Harousseau JL., Proteasome inhibitors in multiple myeloma: ten years later., «BLOOD», 2012, --, pp. 1 - 47 [articolo]
Kumar S.K.; Lee J.H.; Lahuerta J.J.; Morgan G.; Richardson P.G.; Crowley J.; Haessler J.; Feather J.; Hoering A.; Moreau P.; LeLeu X.; Hulin C.; Klein S.K.; Sonneveld P.; Siegel D.; Bladé J.; Goldschmidt H.; Jagannath S.; Miguel J.S.; Orlowski R.; Palumbo A.; Sezer O.; Rajkumar S.V.; Durie B.G. International Myeloma Working Group
Abildgaard N; Abonour R; Alexanian R; Alsina M; Anderson KC; Attal M; Avet-Loiseau H; Badros A; Baris D; Barlogie B; Bataille R; Beksaç M; Belch A; Ben-Yehuda D; Bensinger B; Bergsagel PL; Bird J; Bladé J; Boccadoro M; Cavo M; Chanan-Khan A; Chen WM; Child T; Chim J; Chng WJ; Comenzo R; Crowley J; Dalton W; Davies F; de Souza C; Delforge M; Dimopoulos M; Dispenzieri A; Drach J; Drake M; Durie BG; Einsele H; Facon T; Fantl D; Fermand JP; Fonseca R; Gahrton G; García-Sanz R; Gasparetto C; Gertz M; Gibson J; Giralt S; Goldschmidt H; Greipp P; Hajek R; Hardan I; Hari P; Harousseau JL; Hata H; Hattori Y; Heffner T; Ho J; Hungria V; Ida S; Jacobs P; Jagannath S, Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study., «LEUKEMIA», 2012, 26, pp. 149 - 157 [articolo]
Barosi G; Merlini G; Billio A; Boccadoro M; Corradini P; Marchetti M; Massaia M; Tosi P; Palumbo A; Cavo M; Tura S., SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma., «ANNALS OF HEMATOLOGY», 2012, 91, pp. 875 - 888 [articolo]
Mancini; Elisa Leo; Elena Zamagni; Paola Tacchetti; Annamaria Brioli; Lucia Pantani; Beatrice Anna Zannetti; Giovanni Martinelli; Michele Cavo, SIRT Regulates the Molecular Interaction Between c-MYC and HIF-1α in Multiple Myeloma, in: Blood, «BLOOD», 2012, 120(21), pp. 574 - 574 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [atti di convegno-abstract]
Elena Zamagni;Michele Cavo, The role of imaging techniques in the management of multiple myeloma, «BRITISH JOURNAL OF HAEMATOLOGY», 2012, 159, pp. 499 - 513 [articolo]
Terragna, C ; Remondini, D; Durante, S; Martello, M; Patriarca, F; Levi, A; Pantani, L; Donnarumma, D ; Crippa, C; Bringhen, S; Rambaldi, A ; Offidani, M; Corradini, P; Narni, F; Fioritoni, G; Zaccaria, A; Baldini, L; Caravita, T; La Nasa, G; Cortelazzo, S; Martinelli, G; Baccarani, M; Cavo, M, A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM), in: Blood, 2011, pp. 366 - 366 (atti di: 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 10-13, 2011) [atti di convegno-abstract]
Cavo M., A third-generation IMiD for MM., «BLOOD», 2011, 118, pp. 2931 - 2932 [replica/breve intervento]
Palumbo A.; Cavo M.; Bringhen S.; Zamagni E.; Romano A.; Patriarca F.; Rossi D.; Gentilini F.; Crippa C.; Galli M.; Nozzoli C.; Ria R.; Marasca R.; Montefusco V.; Baldini L.; Elice F.; Callea V.; Pulini S.; Carella A.M.; Zambello R.; Benevolo G.; Magarotto V.; Tacchetti P.; Pescosta N.; Cellini C.; Polloni C.; Evangelista A.; Caravita T.; Morabito F.; Offidani M.; Tosi P.; Boccadoro M., Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial., «JOURNAL OF CLINICAL ONCOLOGY», 2011, 29, pp. 986 - 993 [articolo]
Munshi N.C.; Anderson K.C.; Bergsagel P.L.; Shaughnessy J.; Palumbo A.; Durie B.; Fonseca R.; Stewart A.K.; Harousseau J.L.; Dimopoulos M.; Jagannath S.; Hajek R.; Sezer O.; Kyle R.; Sonneveld P.; Cavo M.; Rajkumar S.V.; San Miguel J.; Crowley J.; Avet-Loiseau H.; International Myeloma Workshop Consensus Panel 2., Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2, «BLOOD», 2011, 117, pp. 4696 - 4700 [articolo]
